Skip to main content
OpenTrials
Completed

NCT Number: NCT05653999

Assessing Speech Perception and Amplification Benefit During Infancy

The goal of this project is to compare aided and unaided speech discrimination among infants with hearing loss and a cohort of infants with typical hearing.

Working Hypothesis: Among this group of infants with hearing loss, performance will be significantly better when infants are tested while using amplification (i.e., aided condition) compared to when tested without amplification (i.e., unaided condition). Infants fit with optimally programmed amplification will perform similarly to the infants with typical hearing on speech discrimination tasks.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–36 month

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Colorado School of Medicine - Speech Perception Over Time Lab

Aurora, Colorado, 80045, United States

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Children between the ages of 6 months and 36 months (inclusive) at the time of enrollment.
  • English is the primary spoken language in the home
  • Demonstrated ability to complete a conditioned head turn via visual reinforcement audiometry (VRA)
  • If normal hearing

-Normal hearing sensitivity bilaterally

  • If Hearing Loss
  • Children with diagnosis of bilateral sensorineural hearing ranging from mild to severe
  • Children currently using hearing aids
  • Children currently enrolled in intervention

Exclusion criteria

  • Children born earlier than 35 weeks gestation
  • Children with abnormal tympanometry on the day of testing
  • Children with concerns of secondary disabilities
  • Children with Auditory Neuropathy
  • Concerns of hearing loss in normal hearing children

Treatment and study plan

hearing aids

Device

Hearing aids will be used by infants with a diagnosed sensorineural hearing loss.

Primary outcomes

  1. Behavioral Speech Perception

    Time frame: Through study completion, up to 6 weeks pending subject factors (e.g., fatigue, otitis media)

    To measure speech perception ability, infants are trained to complete a task in response to a change in a speech sound played over a speaker. Scores are given in d' (or equivalent) and are calculated from both true and false responses. Scores can range from 0.97 and 3.00. Scores above 1.2 are considered significantly above chance indicating successful perception of speech contrasts. To separate issues such as speech discrimination abilities versus proper conditioning, if a child is unable to discriminate a speech contrast (e.g., /ba-da/ or /sa-sha/) testing will transition to the 'easier' speech contrast /a-i/. If the child can discriminate between /a-i/, the investigators will repeat the previously tested contrast. Upon completion of this contrast the next contrast in will be assessed based on randomization ordering. If either contrast was not assessed/the child did not reach criterion, the participant will be rescheduled within 1 month, pending subject factors.

Secondary outcomes

  1. Aided Behavioral Speech Perception Improvement

    Time frame: Through study completion, up to 6 weeks pending subject factors (e.g., fatigue, otitis media)

    Scores are measured from 0 to 2.03. Higher scores indicate greater benefit from hearing aid use in the hearing loss cohort.

Sponsors and collaborators

Lead sponsor

University of Colorado, Denver

Other

Collaborators

  • Sonova AG

Registry information

Important dates

Study start
2023
Primary completion
2025
Study completion
2025
First posted
Dec 16, 2022
Registry last updated
Jun 4, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.